MetLife Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,695
Closed -$2.6M 2845
2025
Q1
$2.6M Sell
10,695
-153
-1% -$37.3K 0.01% 916
2024
Q4
$3.56M Buy
10,848
+948
+10% +$311K 0.02% 750
2024
Q3
$3.31M Buy
9,900
+4,478
+83% +$1.5M 0.02% 765
2024
Q2
$1.48M Buy
5,422
+529
+11% +$144K 0.01% 1134
2024
Q1
$1.69M Sell
4,893
-182
-4% -$62.9K 0.01% 1037
2023
Q4
$1.64M Sell
5,075
-94
-2% -$30.4K 0.01% 1034
2023
Q3
$1.85M Sell
5,169
-243
-4% -$87.1K 0.01% 932
2023
Q2
$2.05M Sell
5,412
-143
-3% -$54.2K 0.01% 925
2023
Q1
$2.66M Sell
5,555
-9
-0.2% -$4.31K 0.02% 800
2022
Q4
$2.34M Sell
5,564
-69
-1% -$29K 0.02% 838
2022
Q3
$2.35M Sell
5,633
-138
-2% -$57.6K 0.02% 809
2022
Q2
$2.86M Sell
5,771
-46
-0.8% -$22.8K 0.02% 745
2022
Q1
$3.28M Buy
5,817
+1,097
+23% +$618K 0.02% 782
2021
Q4
$3.57M Sell
4,720
-65
-1% -$49.1K 0.03% 584
2021
Q3
$3.57M Sell
4,785
-142
-3% -$106K 0.03% 542
2021
Q2
$3.17M Sell
4,927
-139
-3% -$89.6K 0.03% 643
2021
Q1
$2.89M Sell
5,066
-92
-2% -$52.5K 0.03% 694
2020
Q4
$3.01M Sell
5,158
-195
-4% -$114K 0.03% 620
2020
Q3
$2.76M Sell
5,353
-190
-3% -$97.9K 0.03% 576
2020
Q2
$2.5M Sell
5,543
-6,860
-55% -$3.1M 0.03% 618
2020
Q1
$4.35M Hold
12,403
0.06% 295
2019
Q4
$4.59M Sell
12,403
-98
-0.8% -$36.3K 0.05% 394
2019
Q3
$4.16M Buy
12,501
+632
+5% +$210K 0.05% 413
2019
Q2
$3.71M Sell
11,869
-408
-3% -$128K 0.04% 501
2019
Q1
$3.75M Sell
12,277
-3
-0% -$917 0.04% 489
2018
Q4
$2.85M Buy
12,280
+12
+0.1% +$2.79K 0.03% 571
2018
Q3
$3.84M Sell
12,268
-462
-4% -$145K 0.04% 514
2018
Q2
$3.67M Buy
12,730
+115
+0.9% +$33.2K 0.04% 479
2018
Q1
$3.16M Sell
12,615
-175
-1% -$43.8K 0.04% 578
2017
Q4
$3.05M Buy
+12,790
New +$3.05M 0.03% 629